首页|肿瘤坏死因子α在肝细胞癌中的研究进展

肿瘤坏死因子α在肝细胞癌中的研究进展

扫码查看
肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)是一种多功能炎性细胞因子,在肿瘤发生和发展中具有双向调节作用,对肝细胞癌(hepatocellular carcinoma,HCC)的发生、发展调节途径多样,机制尚不完全清楚.血管内皮生长因子(vascular endothelial growth factor,VEGF)分子信号通路和核因子κB(nuclear factor kappa B,NF-κB)信号通路在HCC发生和发展中扮演着重要的角色.外周血TNF-α浓度和肿瘤组织中TNF-α浓度对HCC患者接受一些治疗后的预后表现出了较好的预测价值,但对接受精确放疗的HCC患者预后预测价值,需要被进一步明确.
Research progress of tumor necrosis factor-α in hepatocellular carcinoma
Tumor necrosis factor-α(TNF-α)is a multifunctional inflammatory cytokine that has a bidirectional regulatory role in the occurrence and development of tumors.TNF-α participates in various regulatory pathways for the occurrence and development of hepatocellular carcinoma(HCC),but the mechanisms are not fully clear.Vascular endothelial growth factor(VEGF)and nuclear factor kappa B(NF-κB)signal pathways are considered as important roles in the occurrence and development of HCC.Peripheral blood TNF-α concentration and tumor tissue TNF-α concentration have shown good predictive values for the prognosis of HCC patients after receiving some treatments.The prognostic predictive value of TNF-α for HCC patients receiving precise radiotherapy needs to be further clarified.

tumor necrosis factor-αhepatocellular carcinomaradiotherapyprognosis

胡永、陈一兴、杜世锁、曾昭冲

展开 >

复旦大学附属中山医院放疗科,上海 200032

肿瘤坏死因子α 肝细胞癌 放射治疗 预后

国家重点研发计划国家重点研发计划

2022YFC25037042022YFC2503700

2024

中国临床医学
复旦大学附属中山医院

中国临床医学

CSTPCD
影响因子:1.002
ISSN:1008-6358
年,卷(期):2024.31(2)
  • 58